Synlogic announces termination of abbvie collaboration agreement

Synlogic announces termination of abbvie collaboration agreement.synlogic inc - termination of deal with abbvie for development of synthetic biotic medicines for potential treatment of inflammatory bowel disease.synlogic inc - abbvie and synlogic have been prosecuting specified synthetic biotic programs through discovery activities.synlogic inc - abbvie, co have decided to terminate their collaboration on programs.synlogic inc - synlogic further regains rights to partner its ibd programs.synlogic - upon termination, synlogic regains all rights to develop programs and new ibd synthetic biotic medicines for all effectors targeting ibd.
SYBX Ratings Summary
SYBX Quant Ranking